InventisBio Co Ltd

688382

Company Profile

  • Business description

    InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

  • Contact

    No. 4, Lane 67, Li Bing Road
    Room 210
    Pilot Free Trade Zone
    Shanghai201203
    CHN

    T: +86 2150778527

    http://www.inventisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    185

Stocks News & Analysis

stocks

Our three most overvalued ASX shares

These three companies are trading at a significant premium to our fair value.
stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks

Our only 5-star wide moat ASX share

A difficult year but better times ahead.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,115.7013.70-0.15%
CAC 407,674.7824.14-0.31%
DAX 4023,596.98173.35-0.73%
Dow JONES (US)45,400.86220.43-0.48%
FTSE 1009,208.218.66-0.09%
HKSE25,508.1790.190.35%
NASDAQ21,700.397.30-0.03%
Nikkei 22543,555.43536.681.25%
NZX 50 Index13,263.1839.650.30%
S&P 5006,481.5020.58-0.32%
S&P/ASX 2008,839.8015.40-0.17%
SSE Composite Index3,818.826.310.17%

Market Movers